Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels
Conditions: Hypercholesterolemia; Dyslipidemias Intervention: Behavioral: lipodia Sponsors: Gaia AG; University Hospital, Aachen; Deutsche Stiftung für chronisch Kranke Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
The effect of a multi-component behavior change technique intervention on medication adherence among individuals on primary prevention statin therapy: a dose-finding protocol
This study aims to determine the necessary dose of a multi-component BCT intervention (defined as duration in weeks) to promote adherence to statin medication among those on primary prevention statin treatment by utilizing the modified time-to-event continuous reassessment method (TiTE-CRM).Methods and designThe study will utilize the modified TiTE-CRM in 42 participants, recruited in 14 cohorts of 3 participants each. The goal of this analysis is to identify the minimum effective dose (MED) of a multi-behavior change technique (BCT) intervention required to increase adherence to statins by 20% between baseline and follow-...
Source: Trials - August 12, 2023 Category: Research Source Type: clinical trials
Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels
Conditions: Hypercholesterolemia; Dyslipidemias Intervention: Behavioral: lipodia Sponsors: Gaia AG; University Hospital, Aachen; Deutsche Stiftung für chronisch Kranke Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2023 Category: Research Source Type: clinical trials
Rosuvastatin and Evolocumab for Coronary Artery Disease
Condition: Coronary Artery Disease Interventions: Drug: statin; Drug: evolocumab Sponsor: Icahn School of Medicine at Mount Sinai Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials
